Featuring the latest ductal carcinoma in situ (DCIS) news and updates from DCIS Understood, including program developments, research information, patient stories, advocacy opportunities, and organizational news.

If you've had a lumpectomy for DCIS, you probably remember waiting on your pathology report — and hoping for the words “clear margins.” Many patients also remember the follow-up conversation: what happens if the margin, the rim of healthy tissue around the removed tissue, comes back narrower than your surgeon would like? For years, the answer has often been a second surgery. A large new analysis of a major randomized trial suggests that answer may be due for a second look.

If you've been diagnosed with ductal carcinoma in situ (DCIS), you have likely encountered one of the most frustrating truths about this diagnosis: doctors still can't say for certain whether your particular DCIS will stay put or eventually become invasive. That uncertainty drives real decisions — about surgery, radiation, hormone therapy — for the roughly 55,000 to 60,000 women diagnosed with DCIS in the U.S. each year. A new study about obesity and DCIS offers a promising piece of the puzzle.

If you’ve been treated for ductal carcinoma in situ (DCIS) and had a conversation with your doctor about tamoxifen, you may have heard about a lower-dose option sometimes called “baby TAM.” New research presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June 2026 — and simultaneously published in the Journal of Clinical Oncology — sheds important light on how well this low-dose approach works, and why your menopausal status may matter more than previously understood.

If you’ve been diagnosed with ductal carcinoma in situ (DCIS), one of the biggest questions you may face is whether to have radiation after surgery. A new study published in Clinical Breast Cancer offers reassuring news: long-term quality of life and fear of recurrence may be similar whether or not radiation is part of your treatment. But nearly eight years after diagnosis, many women still overestimate their risk of recurrence — pointing to an important opportunity for clearer patient education.
Subscribe
Subscribe below for the latest DCIS news and updates



